Aung KoKo, Lorenzo Carlos, Hinojosa Marco A, Haffner Steven M
Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.
J Clin Endocrinol Metab. 2014 Feb;99(2):462-8. doi: 10.1210/jc.2013-2832. Epub 2013 Nov 20.
The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities.
We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals.
We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y).
Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively.
MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities.
In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories.
The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.
与肥胖相关的心血管疾病(CVD)和2型糖尿病(DM)风险似乎受其他代谢异常共存的影响。
我们研究了代谢健康的肥胖(MHO)和代谢不健康的正常体重(MUH-NW)个体发生CVD和DM的风险。
我们分析了圣安东尼奥心脏研究的前瞻性数据,这是一项针对墨西哥裔美国人及非西班牙裔白人的人群研究(中位随访时间为7.4年)。
分别对2814名年龄在25至64岁的参与者评估了新发DM情况,对3700名参与者评估了新发CVD情况。
MHO定义为肥胖(体重指数≥30kg/m²)且代谢异常不超过一项,MUH-NW定义为体重指数<25kg/m²且存在两项或更多异常。
在逻辑回归模型中,在控制了人口统计学因素、DM家族史和空腹血糖后,BMI与新发DM相关(优势比×1个标准差为1.7 [95%可信区间,1.5 - 2.0])。MUH-NW和MHO个体发生DM的风险均增加(分别为2.5 [1.1 - 5.6]和3.9 [2.0 - 7.4])。同样,在调整了人口统计学因素和弗雷明汉风险评分后,BMI与新发CVD相关(1.3 [1.1 - 1.6])。MUH-NW和MHO个体发生新发CVD的情况也增加(分别为2.9 [1.3 - 6.4]和3.9 [1.9 - 7.8])。结果在性别和种族类别中均一致。
MUH-NW和MHO个体发生DM和CVD的风险增加。临床实践中应常规筛查肥胖及其他代谢异常,以采取适当的预防措施。